ICPT
Intercept Pharmaceuticals Inc
Price:  
19.00 
USD
Volume:  
3,906,757.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

ICPT WACC - Weighted Average Cost of Capital

The WACC of Intercept Pharmaceuticals Inc (ICPT) is 6.4%.

The Cost of Equity of Intercept Pharmaceuticals Inc (ICPT) is 7.55%.
The Cost of Debt of Intercept Pharmaceuticals Inc (ICPT) is 5.00%.

Range Selected
Cost of equity 6.50% - 8.60% 7.55%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 5.00% - 5.00% 5.00%
WACC 5.6% - 7.2% 6.4%
WACC

ICPT WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.56 0.67
Additional risk adjustments 0.0% 0.5%
Cost of equity 6.50% 8.60%
Tax rate 26.20% 27.00%
Debt/Equity ratio 0.42 0.42
Cost of debt 5.00% 5.00%
After-tax WACC 5.6% 7.2%
Selected WACC 6.4%